Clinical Trials Browser

Completed × Urethral Neoplasms × eribulin × Clear all

NCT02178241 2019-12-16

Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery

Phase 2 Completed

26 enrolled 9 charts

Ureteral Neoplasms, Urethral Neoplasms